Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1983 1
1991 1
1993 1
1995 1
2003 1
2004 1
2008 2
2009 3
2010 2
2011 1
2012 5
2013 1
2015 2
2016 3
2017 1
2018 1
2019 1
2020 2
2021 1
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Individual reserve in aging and neurological disease.
Holtzer R, Choi J, Motl RW, Foley FW, Picone MA, Lipton ML, Izzetoglu M, Hernandez M, Wagshul ME. Holtzer R, et al. Among authors: picone ma. J Neurol. 2023 Jun;270(6):3179-3191. doi: 10.1007/s00415-023-11656-8. Epub 2023 Mar 12. J Neurol. 2023. PMID: 36906731 Free PMC article.
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.
The presence of SARS-CoV2 antibodies in MS patients.
Wallach AI, Picone MA. Wallach AI, et al. Among authors: picone ma. Mult Scler Relat Disord. 2021 May;50:102793. doi: 10.1016/j.msard.2021.102793. Epub 2021 Jan 23. Mult Scler Relat Disord. 2021. PMID: 33588315 Free PMC article.
Identifying and treating patients with suboptimal responses.
Cohen BA, Khan O, Jeffery DR, Bashir K, Rizvi SA, Fox EJ, Agius M, Bashir R, Collins TE, Herndon R, Kinkel P, Mikol DD, Picone MA, Rivera V, Tornatore C, Zwibel H. Cohen BA, et al. Among authors: picone ma. Neurology. 2004 Dec 28;63(12 Suppl 6):S33-40. doi: 10.1212/wnl.63.12_suppl_6.s33. Neurology. 2004. PMID: 15623669 Review.
Suicidal thinking in multiple sclerosis.
Gaskill A, Foley FW, Kolzet J, Picone MA. Gaskill A, et al. Among authors: picone ma. Disabil Rehabil. 2011;33(17-18):1528-36. doi: 10.3109/09638288.2010.533813. Epub 2010 Nov 22. Disabil Rehabil. 2011. PMID: 21091136
36 results